PL360410A1 - Sposób wytwarzania utajonej antytrombiny III - Google Patents

Sposób wytwarzania utajonej antytrombiny III

Info

Publication number
PL360410A1
PL360410A1 PL36041001A PL36041001A PL360410A1 PL 360410 A1 PL360410 A1 PL 360410A1 PL 36041001 A PL36041001 A PL 36041001A PL 36041001 A PL36041001 A PL 36041001A PL 360410 A1 PL360410 A1 PL 360410A1
Authority
PL
Poland
Prior art keywords
preparation
antithrombin iii
latent antithrombin
latent
iii
Prior art date
Application number
PL36041001A
Other languages
English (en)
Inventor
Goeran Karlsson
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0004086A external-priority patent/SE0004086D0/xx
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of PL360410A1 publication Critical patent/PL360410A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL36041001A 2000-11-08 2001-11-08 Sposób wytwarzania utajonej antytrombiny III PL360410A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0004086A SE0004086D0 (sv) 2000-11-08 2000-11-08 Preparation process
US25214800P 2000-11-20 2000-11-20

Publications (1)

Publication Number Publication Date
PL360410A1 true PL360410A1 (pl) 2004-09-06

Family

ID=26655296

Family Applications (1)

Application Number Title Priority Date Filing Date
PL36041001A PL360410A1 (pl) 2000-11-08 2001-11-08 Sposób wytwarzania utajonej antytrombiny III

Country Status (15)

Country Link
EP (1) EP1332159A1 (pl)
JP (1) JP2004522707A (pl)
KR (1) KR20030057545A (pl)
AU (1) AU2002214468A1 (pl)
BR (1) BR0115188A (pl)
CA (1) CA2428055A1 (pl)
CZ (1) CZ20031277A3 (pl)
EE (1) EE200300218A (pl)
HU (1) HUP0301766A3 (pl)
IL (1) IL155539A0 (pl)
MX (1) MXPA03004030A (pl)
NO (1) NO20032048L (pl)
PL (1) PL360410A1 (pl)
RU (1) RU2003117016A (pl)
WO (1) WO2002038610A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
SE0203770D0 (sv) * 2002-12-19 2002-12-19 Biovitrum Ab Method of separation
JP4510898B2 (ja) 2005-02-07 2010-07-28 ハヌマン リミテッド ライアビリティ カンパニー 血漿濃縮装置
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
EP2146794B1 (en) 2007-04-12 2016-10-19 Biomet Biologics, LLC Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
EP2620139B1 (en) 2008-02-27 2016-07-20 Biomet Biologics, LLC Interleukin-1 receptor antagonist rich solutions
EP2254991B1 (en) 2008-02-29 2018-08-22 Biomet Manufacturing, LLC A system and process for separating a material
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device

Also Published As

Publication number Publication date
BR0115188A (pt) 2004-02-03
IL155539A0 (en) 2003-11-23
CZ20031277A3 (cs) 2003-08-13
MXPA03004030A (es) 2004-02-12
HUP0301766A3 (en) 2005-12-28
HUP0301766A2 (hu) 2003-08-28
NO20032048D0 (no) 2003-05-07
JP2004522707A (ja) 2004-07-29
AU2002214468A1 (en) 2002-05-21
WO2002038610A1 (en) 2002-05-16
EP1332159A1 (en) 2003-08-06
CA2428055A1 (en) 2002-05-16
EE200300218A (et) 2003-08-15
RU2003117016A (ru) 2004-12-10
NO20032048L (no) 2003-05-07
KR20030057545A (ko) 2003-07-04

Similar Documents

Publication Publication Date Title
HUP0301766A3 (en) Process for the preparation of latent antithrombin iii
HK1052183A1 (zh) 製造tetrahydrobenzothiepines的方法
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
IL153532A0 (en) Process for the preparation of pyrazolopyrimidinones
AU8824201A (en) Process for the preparation of dinapsoline
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
IL137364A (en) Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
AU5462901A (en) Process for the preparation of (pyridinylidene)-phthalides
PL368905A1 (pl) Sposób otrzymywania beta-jonylidenoacetaldehydu
GB0012249D0 (en) Process for the preparation of 11-oxaprostaglandins
IL154804A0 (en) Process for the preparation of thiophenols
IL152983A0 (en) Novel process for the preparation of pyrazolopyrimidinones
HRP20000680B1 (en) Process for the preparation of fluconazole
HU0003616D0 (en) Process for the preparation of pyridyl-ketone
GB0012996D0 (en) Process for the preparation of endo-5-norbornene-2-ol
GB0028881D0 (en) Process for the preparation of endo-5-norbornene-2-ol
AU2002231651A1 (en) Process for the preparation of morpholinones
IL155995A0 (en) New process for the preparation of diaryl-4-amino-piperidinyl compounds
GB0015462D0 (en) Novel process for the preparation of pyrazolopyrimidinones
SI1385850T1 (en) New process for the preparation of oxabispidines
GB0113667D0 (en) Process for the preparation of endo-5-norbornene-2-ol
HRP20010190B1 (en) Process for the preparation of alpha-arbutine